Molecular Biology Terms Starting With R

Regulatory Region is a DNA sequence that controls the expression of nearby or distant genes by providing binding sites for transcription factors, chromatin remodeling complexes, and other regulatory proteins.

Regulatory regions include core promoters where RNA polymerase binds, proximal elements within a few hundred base pairs of the transcription start site, and distal enhancers that can function hundreds of kilobases away to increase transcription rates 10-fold or more. Insulators such as CTCF-binding sites define domain boundaries and prevent enhancers from activating inappropriate genes, while locus control regions coordinate expression of gene clusters such as the beta-globin locus. Open chromatin signatures, conservation across species, and histone modifications like H3K4me3 at promoters or H3K27ac at active enhancers help researchers identify these sequences.

Mutations in regulatory regions cause many human diseases without altering any protein-coding sequence.

Replication Fork is the Y-shaped structure formed at an active origin of replication where the two parental DNA strands are separated and new complementary strands are synthesized bidirectionally.

At each replication fork, helicase unwinds the double helix, single-strand binding proteins stabilize the exposed strands, and primase synthesizes RNA primers to initiate synthesis on both strands. DNA polymerase synthesizes the leading strand continuously in the direction of fork movement and the lagging strand discontinuously as Okazaki fragments, each roughly 100 to 200 nucleotides long in eukaryotes, moving away from the fork. Fork progression reaches about 50 base pairs per second in human cells, compared with roughly 1,000 base pairs per second in Escherichia coli.

Stalled forks can collapse to produce double-strand breaks that are repaired by homologous recombination.

Reverse Primer is a short synthetic oligonucleotide that anneals to the antisense strand of double-stranded DNA at the downstream end of a target sequence, priming DNA synthesis toward the forward primer during PCR.

In PCR, the reverse primer and forward primer flank the target sequence from opposite strands, directing DNA polymerase to synthesize new strands toward each other and amplify the region between them exponentially. The reverse primer sequence is complementary to the antisense strand, meaning it shares the same sequence as the sense strand but is oriented 3-prime to 5-prime relative to that strand. Primer length typically ranges from 18 to 25 nucleotides, and melting temperatures for the forward and reverse primers are matched within 2 to 5 degrees Celsius to ensure both anneal efficiently during the same PCR cycle.

Self-complementarity within or between primers must be avoided to prevent hairpin formation or primer-dimer artifacts that reduce amplification efficiency.

Reverse Transcription is the synthesis of complementary DNA from an RNA template by the enzyme reverse transcriptase.

Reverse transcriptase, encoded by retroviruses such as HIV, first synthesizes a DNA-RNA hybrid duplex using the viral RNA genome as a template. Its associated RNase H activity then degrades the RNA strand of that hybrid, and a second DNA strand is synthesized to produce a complete double-stranded cDNA. In molecular biology, reverse transcription is combined with PCR in the RT-PCR technique to detect and quantify specific RNA sequences by converting them to cDNA before amplification.

Retrotransposons, which make up a substantial fraction of many eukaryotic genomes, also use reverse transcription to copy themselves into new genomic locations.

Riboswitch is a segment of messenger RNA that folds into distinct secondary structures depending on whether a specific small molecule is bound, and this conformational change directly controls transcription termination or translation initiation without requiring any protein regulator.

Riboswitches are found predominantly in bacteria, where they are embedded in the 5-prime untranslated regions of mRNAs encoding metabolic enzymes. Each riboswitch contains an aptamer domain that binds its target ligand with high specificity and an expression platform whose folding state determines whether the downstream gene is expressed. When intracellular concentrations of a metabolite such as adenosylcobalamin rise above a threshold, ligand binding stabilizes a terminator hairpin that halts transcription before the coding sequence is reached.

More than 40 distinct riboswitch classes have been identified in bacteria, each recognizing a different small molecule including amino acids, nucleotides, metal ions, and enzyme cofactors.

Ribozyme is an RNA molecule that catalyzes a chemical reaction, most commonly the cleavage or formation of phosphodiester bonds, demonstrating that proteins are not the only biological molecules capable of enzymatic activity.

The discovery of ribozymes by Thomas Cech and Sidney Altman in the early 1980s, work that earned them the 1989 Nobel Prize in Chemistry, overturned the long-held assumption that all biological catalysts are proteins. Cech showed that the group I intron of Tetrahymena thermophila (a ciliated protozoan) could splice itself out of a precursor RNA without any protein assistance. The most biologically significant ribozyme is the ribosome itself: the peptidyl transferase center that forms peptide bonds during translation is composed of ribosomal RNA, not protein, meaning every living cell continuously uses RNA catalysis to build its proteome.

Some ribozymes, such as the hammerhead and hairpin ribozymes found in plant viroids, cleave RNA strands with rate enhancements of up to 10 million-fold over the uncatalyzed reaction.

RISC is a ribonucleoprotein complex that uses a short single-stranded RNA guide to locate complementary messenger RNA molecules and silence them by cleavage or translational repression.

The core of RISC is an Argonaute protein that binds a guide RNA strand of 21 to 23 nucleotides derived from small interfering RNA or microRNA processing. When the guide sequence matches a target mRNA with full complementarity, the Argonaute slicer domain cleaves the mRNA at a position precisely 10 nucleotides from the guide’s 5 end, marking it for rapid degradation. Partial complementarity, which is typical of most animal microRNA-target interactions, instead recruits GW182 scaffold proteins and deadenylase complexes that shorten the mRNA’s poly-A tail and block ribosome access.

RISC-mediated silencing defends plants, animals, and fungi against RNA viruses and fine-tunes developmental gene expression programs across hundreds of target transcripts simultaneously. Caenorhabditis elegans provided the first genetic evidence for this pathway when Andrew Fire and Craig Mello demonstrated in 1998 that injected double-stranded RNA silenced matching genes far more potently than single-stranded RNA alone.

RNA Interference is a conserved cellular mechanism in which double-stranded RNA triggers sequence-specific silencing of gene expression by directing degradation or translational repression of complementary messenger RNA.

The pathway begins when the enzyme Dicer cleaves long double-stranded RNA or pre-microRNA hairpins into short duplexes of approximately 21 to 23 nucleotides. One strand of each duplex loads into the RNA-induced silencing complex, where it guides RISC to complementary mRNA targets. Perfect complementarity between the guide and target triggers Argonaute-mediated mRNA cleavage, while partial complementarity recruits deadenylases and translational repressors that reduce protein output without destroying the transcript immediately.

Andrew Fire and Craig Mello discovered the mechanism in Caenorhabditis elegans in 1998 and received the Nobel Prize in Physiology or Medicine in 2006 for the work. Researchers now exploit the pathway therapeutically: inclisiran, approved by the FDA in 2021, uses small interfering RNA to silence PCSK9 mRNA in liver cells and lower LDL cholesterol in patients with cardiovascular disease.

RNA Polymerase II is the eukaryotic enzyme that transcribes protein-coding genes and most non-coding RNA genes from a DNA template into precursor RNA molecules.

RNA Polymerase II moves along the template DNA strand in the 3-to-5 direction, adding ribonucleotides to the growing RNA chain in the 5-to-3 direction at approximately 20 to 40 nucleotides per second in mammalian cells. General transcription factors assemble at core promoter elements such as the TATA box to position the enzyme at the transcription start site, and the Mediator complex relays signals from enhancer-bound activators to the polymerase. Shortly after synthesis begins, capping enzymes add a 7-methylguanosine cap to the 5 end of the nascent RNA, protecting it from exonuclease degradation and facilitating ribosome recognition.

Promoter-proximal pausing, in which the polymerase stalls 20 to 60 nucleotides downstream of the start site, is a widespread regulatory checkpoint that controls the rate of productive elongation across thousands of human genes. Beyond messenger RNA, RNA Polymerase II transcribes long non-coding RNAs, microRNA precursors, and small nuclear RNAs that are processed into spliceosomal components.

RNA Secondary Structure is the set of base-paired regions and unpaired loops that form when complementary sequences within a single RNA strand fold back and hydrogen-bond with each other, producing a characteristic two-dimensional shape that influences the RNA's function.

Unlike double-stranded DNA, a single RNA strand can pair with itself wherever complementary sequences occur within the same molecule, forming stem-loops, hairpins, internal loops, and bulges stabilized by Watson-Crick and wobble base pairs. These structures are thermodynamically stable under physiological conditions and are encoded directly by the RNA sequence, meaning that two RNAs with different sequences but similar folding patterns can perform equivalent functions. Ribosomal RNA provides the most dramatic example: the 16S rRNA of Escherichia coli folds into more than 50 distinct helical stems that together form the structural scaffold of the small ribosomal subunit, with individual stems conserved across billions of years of evolution.

Regulatory RNA structures called riboswitches in bacterial mRNA leaders change conformation when a small molecule binds, toggling transcription termination or translation initiation on or off without any protein intermediary. Computational tools such as the Zuker algorithm predict minimum free-energy secondary structures from sequence alone, though experimental methods including SHAPE chemistry are needed to confirm folding in living cells.

RNA-Dependent DNA Polymerase is an enzyme that synthesizes a new DNA strand by reading an RNA template, a reaction used by retroviruses and retrotransposons to convert RNA genetic information back into DNA.

This enzyme, universally called reverse transcriptase, was discovered independently by Howard Temin and David Baltimore in 1970 and overturned the assumption that genetic information flows only from DNA to RNA to protein. Retroviral reverse transcriptase carries three catalytic activities in a single polypeptide: RNA-dependent DNA polymerase activity to copy the RNA genome into a complementary DNA strand, RNase H activity to degrade the RNA strand of the resulting RNA-DNA hybrid, and DNA-dependent DNA polymerase activity to synthesize the second DNA strand. HIV reverse transcriptase introduces approximately one error per 10,000 nucleotides copied because it lacks a proofreading exonuclease, generating the genetic diversity that underlies rapid drug resistance.

The enzyme requires a primer to begin synthesis; HIV uses a host transfer RNA base-paired to the viral RNA genome as its primer. Antiretroviral drugs including tenofovir and emtricitabine inhibit reverse transcriptase and form the backbone of modern HIV treatment regimens.

RNA-Dependent RNA Polymerase is an enzyme that synthesizes RNA using an RNA template, a reaction used by many RNA viruses during genome replication and transcription.

Most RNA viruses that replicate RNA genomes through RNA intermediates encode or package an RNA-dependent RNA polymerase, because uninfected human cells do not normally copy RNA from RNA. Positive-sense RNA viruses such as poliovirus translate the polymerase after entry, while negative-sense RNA viruses such as influenza must package polymerase complexes inside the virion so transcription can begin immediately. Retroviruses are a major exception because they use reverse transcriptase to copy RNA into DNA, and hepatitis delta virus exploits host RNA polymerase activity in an unusual RNA-templated replication strategy.

RNA-dependent RNA polymerases generally have lower fidelity than cellular DNA polymerases, although coronaviruses partially offset this limitation with nsp14 exonuclease proofreading. These enzymes are major antiviral drug targets, including the SARS-CoV-2 polymerase targeted by remdesivir.